Joe Biden Eli Lilly Usa Canada Joe Biden Eli Lilly Usa Canada

No insulin price cut coming for Canada despite U.S. slashes, Eli Lilly says

Reading now: 819
globalnews.ca

insulin products in the United States won’t be coming to Canada, the company tells Global News.The drug manufacturer, which is one of the largest producers in the world, announced Wednesday that it will cut prices for some of its most commonly prescribed insulin products in the United States.By capping the price at US$25 ($35) a vial, and expanding its existing US$35 ($50) cap on some insulin products to 85 per cent of U.S.

pharmacies, it’s expected to provide instant relief to potentially millions of Americans struggling to buy the life-saving diabetes medication.

Read more: As cost of living rises, diabetes remains an expensive condition for Atlantic Canadians But given the “affordability situation” is different in Canada, Eli Lilly said in a statement there will be no changes to its products north of the border.The “announcement is specific to the United States and there are no changes to Lilly’s insulin products here in Canada.

Lilly believes that no Canadian should go without needed medicines for the reason that they cannot afford them,” a spokesperson told Global News on Thursday.“The affordability situation in Canada is quite different from the United States, but we are committed to working with stakeholders to build solutions to address the coverage gaps that exist in Canada.”Canada has drug price controls in place which are set and reviewed by a body called the Patented Medicines Pricing Review Board.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA